Literature DB >> 27802219

Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology.

Rachel H L H Rueli1, Daniel J Torres1, Andrea S T Dewing1, Arlene C Kiyohara1, Stephanie M Barayuga1, Miyoko T Bellinger1, Jane H Uyehara-Lock2, Lon R White3, Paula I Moreira4, Marla J Berry1, George Perry5, Frederick P Bellinger1.   

Abstract

Previous studies demonstrated that selenium in the form of sodium selenate reduces neurofibrillary tangle formation in Alzheimer's disease models. Hyperphosphorylation of tau, which leads to formation of neurofibrillary tangles in Alzheimer's disease, is increased by endoplasmic reticulum (ER) stress. Selenoprotein S (SelS) is part of an ER membrane complex that removes misfolded proteins from the ER as a means to reduce ER stress. Selenate, as with other forms of selenium, will increase selenoprotein expression. We therefore proposed that increased SelS expression by selenate would contribute to the beneficial actions of selenate in Alzheimer's disease. SelS expression increased with ER stress and decreased under conditions of elevated glucose concentrations in the SH-SY5Y neuronal cell line. Reducing expression of SelS with siRNA promoted cell death in response to ER stress. Selenate increased SelS expression, which significantly correlated with decreased tau phosphorylation. Restricting SelS expression during ER stress conditions increased tau phosphorylation, and also promoted aggregation of phosphorylated tau in neurites and soma. In human postmortem brain, SelS expression coincided with neurofibrillary tangles, but not with amyloid-β plaques. These results indicate that selenate can alter phosphorylation of tau by increasing expression of SelS in Alzheimer's disease and potentially other neurodegenerative disorders.

Entities:  

Keywords:  Alzheimer’s disease; endoplasmic reticulum stress; neurofibrillary tangle; selenium; selenoprotein; tau

Mesh:

Substances:

Year:  2017        PMID: 27802219      PMCID: PMC5893862          DOI: 10.3233/JAD-151208

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  57 in total

1.  Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.

Authors:  Tauheed Ishrat; Kehkashan Parveen; Mohd Moshahid Khan; Gulrana Khuwaja; M Badruzzaman Khan; Seema Yousuf; Ajmal Ahmad; Pallavi Shrivastav; Fakhrul Islam
Journal:  Brain Res       Date:  2009-04-15       Impact factor: 3.252

2.  Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models.

Authors:  Nigel C Jones; Thanh Nguyen; Niall M Corcoran; Dennis Velakoulis; Tracy Chen; Robert Grundy; Terence J O'Brien; Christopher M Hovens
Journal:  Neurobiol Dis       Date:  2011-12-11       Impact factor: 5.996

3.  Ebselen inhibits iron-induced tau phosphorylation by attenuating DMT1 up-regulation and cellular iron uptake.

Authors:  Ling Xie; Wei Zheng; Na Xin; Jing-Wei Xie; Tao Wang; Zhan-You Wang
Journal:  Neurochem Int       Date:  2012-05-24       Impact factor: 3.921

4.  The unfolded protein response is activated in Alzheimer's disease.

Authors:  J J M Hoozemans; R Veerhuis; E S Van Haastert; J M Rozemuller; F Baas; P Eikelenboom; W Scheper
Journal:  Acta Neuropathol       Date:  2005-06-23       Impact factor: 17.088

5.  Neuroprotector effect of p,p'-methoxyl-diphenyl diselenide in a model of sporadic dementia of Alzheimer's type in mice: contribution of antioxidant mechanism.

Authors:  Simone Pinton; Juliana Trevisan da Rocha; Bibiana Mozzaquatro Gai; Marina Prigol; Luiz Vinícius da Rosa; Cristina Wayne Nogueira
Journal:  Cell Biochem Funct       Date:  2011-02-24       Impact factor: 3.685

6.  Genetic variation in selenoprotein S influences inflammatory response.

Authors:  Joanne E Curran; Jeremy B M Jowett; Kate S Elliott; Yuan Gao; Kristi Gluschenko; Jianmin Wang; Dalia M Abel Azim; Guowen Cai; Michael C Mahaney; Anthony G Comuzzie; Thomas D Dyer; Ken R Walder; Paul Zimmet; Jean W MacCluer; Greg R Collier; Ahmed H Kissebah; John Blangero
Journal:  Nat Genet       Date:  2005-10-09       Impact factor: 38.330

7.  Development of a serum-free supplement for primary neuron culture reveals the interplay of selenium and vitamin E in neuronal survival.

Authors:  Stephan Roth; Sijie Zhang; Jazmin Chiu; Eva K Wirth; Ulrich Schweizer
Journal:  J Trace Elem Med Biol       Date:  2010-02-02       Impact factor: 3.849

8.  Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.

Authors:  Guoli Song; Zhonghao Zhang; Lei Wen; Chen Chen; Qingxue Shi; Yu Zhang; Jiazuan Ni; Qiong Liu
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

9.  Selenium treatment significantly inhibits tumor necrosis factor-α-induced cell death and tau hyperphosphorylation in neuroblastoma cells.

Authors:  Young Ju Lee; Ji Eun Kim; Moon Hwa Kwak; Jun Go; Seung Yun Yang; Hyeog Soong Kwon; Byoung Chul Kim; Joo Man Kim; Dae Youn Hwang
Journal:  Mol Med Rep       Date:  2014-08-04       Impact factor: 2.952

10.  Hepatitis C virus envelope proteins regulate CHOP via induction of the unfolded protein response.

Authors:  Shiu-Wan Chan; Philip Anthony Egan
Journal:  FASEB J       Date:  2005-07-08       Impact factor: 5.191

View more
  9 in total

Review 1.  Endoplasmic reticulum-resident selenoproteins as regulators of calcium signaling and homeostasis.

Authors:  Matthew W Pitts; Peter R Hoffmann
Journal:  Cell Calcium       Date:  2017-05-04       Impact factor: 6.817

Review 2.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

Review 3.  Tau-targeting therapies for Alzheimer disease.

Authors:  Erin E Congdon; Einar M Sigurdsson
Journal:  Nat Rev Neurol       Date:  2018-07       Impact factor: 42.937

4.  A selenium species in cerebrospinal fluid predicts conversion to Alzheimer's dementia in persons with mild cognitive impairment.

Authors:  Marco Vinceti; Annalisa Chiari; Marcel Eichmüller; Kenneth J Rothman; Tommaso Filippini; Carlotta Malagoli; Jennifer Weuve; Manuela Tondelli; Giovanna Zamboni; Paolo F Nichelli; Bernhard Michalke
Journal:  Alzheimers Res Ther       Date:  2017-12-19       Impact factor: 6.982

5.  Effect of single nucleotide polymorphisms in SEPS1 and SEPP1 on expression in the protein level in metabolic syndrome in subjects with cardiovascular disease.

Authors:  Mojgan Gharipour; Khadija Ouguerram; El-Hassane Nazih; Mansoor Salehi; Mehrdad Behmanesh; Rouzbeh Razavi; Amin Gharipour; Minoo Diantkhah; Masoumeh Sadeghi
Journal:  Mol Biol Rep       Date:  2019-09-21       Impact factor: 2.316

6.  A gene-environment interaction analysis of plasma selenium with prevalent and incident diabetes: The Hortega study.

Authors:  Inmaculada Galan-Chilet; Maria Grau-Perez; Griselda De Marco; Eliseo Guallar; Juan Carlos Martin-Escudero; Alejandro Dominguez-Lucas; Isabel Gonzalez-Manzano; Raul Lopez-Izquierdo; Laisa Socorro Briongos-Figuero; Josep Redon; Felipe Javier Chaves; Maria Tellez-Plaza
Journal:  Redox Biol       Date:  2017-04-14       Impact factor: 11.799

Review 7.  Critical review: involvement of endoplasmic reticulum stress in the aetiology of Alzheimer's disease.

Authors:  Shoko Hashimoto; Takaomi C Saido
Journal:  Open Biol       Date:  2018-04       Impact factor: 6.411

Review 8.  The essential elements of Alzheimer's disease.

Authors:  Peng Lei; Scott Ayton; Ashley I Bush
Journal:  J Biol Chem       Date:  2020-11-27       Impact factor: 5.157

9.  Selenoprotein P Regulates Synaptic Zinc and Reduces Tau Phosphorylation.

Authors:  Arlene C P Kiyohara; Daniel J Torres; Ayaka Hagiwara; Jenna Pak; Rachel H L H Rueli; C William R Shuttleworth; Frederick P Bellinger
Journal:  Front Nutr       Date:  2021-07-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.